PortfoliosLab logoPortfoliosLab logo

Janus Henderson Global Life Sciences Fund Class T (JAGLX) belongs to the Health & Biotech Equities category. Below you'll find alternative mutual funds from the same category, ranked by key criteria, plus funds that investors commonly compare with JAGLX. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to JAGLX

JAGLX charges 0.92% annually. There are 23 mutual funds in the Health & Biotech Equities category with lower expense ratios, going as low as 0.10%.


Best Risk-Adjusted Alternatives to JAGLX

JAGLX has a PortfoliosLab risk / return rank of 79. There are 10 mutual funds in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 94.


Top Performing JAGLX Alternatives (YTD)

JAGLX is at 4.65% YTD. There are 16 mutual funds in the Health & Biotech Equities category with higher YTD returns, going as high as 14.43%.


Lowest Volatility Alternatives to JAGLX

JAGLX has 15.28% 1-year volatility. There are 12 mutual funds in the Health & Biotech Equities category with lower 1-year volatility, going as low as 13.54%.


Lowest Drawdown Alternatives to JAGLX

JAGLX has a 1-year max drawdown of -9.71%. There are 16 mutual funds in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as -7.62%.


Other Mutual Funds from Janus Henderson

The 10 most viewed Janus Henderson mutual funds shown here include JNGTX, JNRFX, JAGTX and span 6 categories.


Often Compared With JAGLX

Investors most often compare JAGLX with VHT, JNGLX, IHE. These 20 comparison targets span 6 categories, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
Vanguard Health Care ETFHealth & Biotech Equities
44
2.53%
19.00BJan 2004JAGLX vs VHT
Janus Henderson Global Life Sciences FundHealth & Biotech Equities
78
4.70%
Dec 1998JAGLX vs JNGLX
iShares U.S. Pharmaceuticals ETFHealth & Biotech Equities
91
13.81%
956.44MMay 2006JAGLX vs IHE
Janus Henderson Global Life Sciences Fund Class AHealth & Biotech Equities
78
4.60%
Dec 1998JAGLX vs JFNAX
iShares U.S. Healthcare Providers ETFHealth & Biotech Equities
21
14.04%
1.11BMay 2006JAGLX vs IHF
VanEck Vectors Biotech ETFHealth & Biotech Equities
52
3.83%
374.51MDec 2011JAGLX vs BBH
Fidelity Global ex U.S. Index FundForeign Large Cap Equities
54
13.13%
Aug 2011JAGLX vs FSGGX
iShares Nasdaq Biotechnology ETFHealth & Biotech Equities
81
8.92%
8.11BFeb 2001JAGLX vs IBB
iShares U.S. Medical Devices ETFHealth & Biotech Equities
2
-19.12%
3.01BMay 2006JAGLX vs IHI
Invesco DWA Basic Materials Momentum ETFMomentum, Materials
48
15.78%
83.33MOct 2006JAGLX vs PYZ
iShares U.S. Healthcare ETFHealth & Biotech Equities
37
1.43%
3.06BJun 2000JAGLX vs IYH
SPDR S&P Pharmaceuticals ETFHealth & Biotech Equities
89
15.46%
364.01MJun 2006JAGLX vs XPH
Saratoga Health & Biotechnology FundHealth & Biotech Equities
29
2.49%
Jul 1999JAGLX vs SHPAX
Eventide Healthcare & Life Sciences FundHealth & Biotech Equities
84
5.52%
Dec 2012JAGLX vs ETIHX
Vanguard Information Technology ETFTechnology Equities
60
22.82%
170.10BMar 2004JAGLX vs VGT
SPDR S&P Biotech ETFHealth & Biotech Equities
94
24.45%
8.62BFeb 2006JAGLX vs XBI
Janus Henderson Global Select FundGlobal Equities
34
7.60%
Jun 2000JAGLX vs JANRX
Alger Health Sciences FundHealth & Biotech Equities
64
7.37%
Apr 2002JAGLX vs AHSAX
T. Rowe Price Health Sciences FundHealth & Biotech Equities
37
2.49%
Dec 1995JAGLX vs PRHSX
Fidelity Advisor Biotechnology Fund Class CHealth & Biotech Equities
90
13.55%
Dec 2000JAGLX vs FBTCX

Compare JAGLX with Any Fund or Stock

Compare JAGLX with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair JAGLX with funds that move differently

Janus Henderson Global Life Sciences Fund Class T alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to JAGLX.

Explore JAGLX Diversifiers